BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8089650)

  • 1. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
    Ferreira GC
    J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
    May BK; Bhasker CR; Bawden MJ; Cox TC
    Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
    Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
    N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for X-linked sideroblastic anemia.
    Yamamoto M; Nakajima O
    Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
    Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
    J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in iron metabolism and iron-related anemia].
    Harigae H
    Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
    Bottomley SS; Healy HM; Brandenburg MA; May BK
    Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.
    Ducamp S; Kannengiesser C; Touati M; Garçon L; Guerci-Bresler A; Guichard JF; Vermylen C; Dochir J; Poirel HA; Fouyssac F; Mansuy L; Leroux G; Tertian G; Girot R; Heimpel H; Matthes T; Talbi N; Deybach JC; Beaumont C; Puy H; Grandchamp B
    Hum Mutat; 2011 Jun; 32(6):590-7. PubMed ID: 21309041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.
    Nakajima O; Okano S; Harada H; Kusaka T; Gao X; Hosoya T; Suzuki N; Takahashi S; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):685-700. PubMed ID: 16716198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
    Wang YQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis.
    Hunter GA; Ferreira GC
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):102-10. PubMed ID: 19268008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroid 5-aminolevulinate synthase is located on the X chromosome.
    Cox TC; Bawden MJ; Abraham NG; Bottomley SS; May BK; Baker E; Chen LZ; Sutherland GR
    Am J Hum Genet; 1990 Jan; 46(1):107-11. PubMed ID: 2294742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mechanisms for hereditary sideroblastic anemia.
    Furuyama K; Sassa S
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular permutation of 5-aminolevulinate synthase as a tool to evaluate folding, structure and function.
    Ferreira GC; Cheltsov AV
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):11-6. PubMed ID: 11929042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.
    Furuyama K; Harigae H; Heller T; Hamel BC; Minder EI; Shimizu T; Kuribara T; Blijlevens N; Shibahara S; Sassa S
    Eur J Haematol; 2006 Jan; 76(1):33-41. PubMed ID: 16343269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome.
    Bishop DF; Henderson AS; Astrin KH
    Genomics; 1990 Jun; 7(2):207-14. PubMed ID: 2347585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.